Gil Blum
Stock Analyst at Needham
(2.06)
# 2,855
Out of 4,883 analysts
393
Total ratings
35.47%
Success rate
-5.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSHA Taysha Gene Therapies | Reiterates: Buy | $8 | $2.34 | +241.88% | 29 | Jul 1, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $12.49 | +132.19% | 17 | Jun 30, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $48.51 | +66.98% | 23 | Jun 26, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.29 | +336.68% | 28 | Jun 12, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $1.53 | +1,076.47% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.59 | +247.49% | 4 | May 14, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $64.78 | +62.10% | 23 | Dec 10, 2024 | |
| IMAB I-Mab | Maintains: Buy | $4 → $5 | $2.34 | +113.68% | 14 | Jun 27, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $125 → $50 | $17.71 | +182.33% | 32 | Jun 16, 2025 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.14 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $42 | $2.59 | +1,521.62% | 21 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.71 | +484.80% | 17 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.76 | +153.62% | 18 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $11.01 | +263.31% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.32 | +2,400.00% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $5.13 | +55.95% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $11.71 | +130.57% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.84 | +116.20% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.43 | +529.37% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.82 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.38 | +262.32% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.84 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.44 | +817.43% | 9 | Aug 2, 2024 |
Taysha Gene Therapies
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.34
Upside: +241.88%
Celcuity
Jun 30, 2025
Reiterates: Buy
Price Target: $29
Current: $12.49
Upside: +132.19%
CRISPR Therapeutics AG
Jun 26, 2025
Reiterates: Buy
Price Target: $81
Current: $48.51
Upside: +66.98%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.29
Upside: +336.68%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $1.53
Upside: +1,076.47%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.59
Upside: +247.49%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $64.78
Upside: +62.10%
I-Mab
Jun 27, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $2.34
Upside: +113.68%
Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125 → $50
Current: $17.71
Upside: +182.33%
Fate Therapeutics
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.14
Upside: -
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $2.59
Upside: +1,521.62%
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.71
Upside: +484.80%
May 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.76
Upside: +153.62%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $11.01
Upside: +263.31%
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.32
Upside: +2,400.00%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $5.13
Upside: +55.95%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $11.71
Upside: +130.57%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.84
Upside: +116.20%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.43
Upside: +529.37%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.82
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.84
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.44
Upside: +817.43%